查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138408

全球药物递送纳米技术市场-2022-2029

Global Nanotechnology in Drug Delivery Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

由于慢性病患病率的增加、各种具有成本效益的新产品的推出和新技术的进步，对纳米技术在药物递送中的需求不断增加，全球纳米技术在药物递送中的市场正在增长。由于多种因素，该市场正在增长。

纳米技术药物输送的批准和各种新技术的进步预计将推动市场的增长。

由于全球不健康的生活方式和环境变化，癌症、肿瘤、心脏病和冠状动脉疾病等慢性疾病的患病率不断上升，推动了市场的发展。根据世界卫生组织（WHO）的数据，癌症将成为 2020 年的首要死因，导致全球 960 万人死亡，每年诊断出超过 300,000 例病例。纳米医学通过减少副作用在改善人类健康方面发挥着重要作用。目前，基于纳米技术的药物递送他汀类药物和纳米抗生素可作为预防癌症和冠状动脉疾病等某些疾病的有效治疗方法。纳米抗生素计划利用这种效应，通过应用提供抗菌治疗的纳米颗粒和改善抗生素药物输送的纳米级生物分子来增强对感染的治疗。

FDA 的批准正在增加。具有广泛研究和开发各种疾病的创新药物的扩散为这个市场创造了充足的机会。例如，2020 年 6 月 17 日，Nanobiotix 公司收到了美国 FDA 关于开发有效设计的基于铂的化疗的反馈。公司通过支持未来新药申请 (NDA) 所需的研究设计，推进基于化学、製造和控制 (CMC) 开发的治疗颈部和头部癌症的 III 期临床试验，因为它已经开始。

与药物输送中的纳米技术相关的担忧预计将阻碍市场增长。

随着纳米技术程序可能导致严重的环境危机并且不环保，环境问题日益增加。使用化学品提取纳米颗粒会增加对环境的污染。与健康相关的担忧也在抑制市场增长。

行业分析

全球药物输送纳米技术市场根据波特五力、监管分析、供应链分析和定价分析等各种行业因素对市场进行了深入分析。

纳米技术在药物输送全球市场报告中提供了对大约 45 多个市场数据表、40 多个数字和 180 页的访问。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 纳米技术药物递送系统的批准增加
      • 技术进步的增加
    • 限制因素
      • 环境和健康风险增加
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析

第 6 章按技术分类

  • 用于纳米技术行业的药物输送胶束
  • 纳米粒子
  • 脂质体
  • 纳米晶体
  • 其他

第 7 章按应用程序

  • 抗感染
  • 神经区域
  • 抗炎/免疫学
  • 肿瘤学
  • 循环系统/生理学
  • 其他

第 8 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 9 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 技术基准
  • 值得关注的重点公司列表

第 10 章公司简介

  • AbbVie Inc.
    • 公司概况
    • 技术组合和内容
    • 主要亮点
    • 财务摘要
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • Nanobiotix
  • NanoCarrier Co. Ltd.
  • NanOlogy LLC
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Ceramisphere Health Pvt Limited
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Lena Nanoceutics Ltd.

第11章 全球药物递送纳米技术市场-DataM

简介目录
Product Code: DMMD2546

Market Overview

Nanotechnology in Drug Delivery Market size was valued US$ 51.4 billion in 2021 and is estimated to reach US$ 203.6 billion by 2029, growing at a CAGR of 17.9% during the forecast period (2022-2029).

Nanotechnology in drug delivery is the rapidly developing way of providing effective treatment for various diseases. Nanotechnology-based drugs can potentially deliver the drugs to targeted and affected parts of the human body by reducing the side effects. Nanotechnology drug delivery utilizes the nanoscale range nanoparticles like liposomes, chemotherapeutic agents, biological agents, etc., to deliver the therapeutic agents to specifically targeted sites in a controlled manner. The nanotechnology drug delivery has certain benefits, including improving the ability to deliver poorly water-soluble drugs, reduce drug accumulation within healthy tissue, combine therapeutic and diagnostic modalities through one agent, transportation of drugs across epithelial and endothelial barriers, protection from the biological environment, effective treatment can be achieved by retaining the drug in the body long time.

Market Dynamics

The global nanotechnology in drug delivery market is growing due to several factors such as rising demand for nanotechnology in drug delivery due to the increasing prevalence of chronic diseases, various new cost-effective product launches and novel technological advances.

Rising approvals of nanotechnology drug delivery and various new technological advancements are expected to drive market growth.

The market is driven by the rising prevalence of chronic ailments like cancer, tumor, heart disease, coronary artery disease due to unhealthy life styles and changing environments worldwide. According to the World Health Organization, in 2020, Cancer is the leading cause of death, accounting for 9.6 million people who died worldwide, and more than 300000 patients are being diagnosed each year. Nanomedicine plays a vital role in enhancing human health by reducing side effects. Currently, nanotechnology-based drug delivery statins, nano antibiotics, and other agents can be utilized as a valid treatment for preventing certain diseases like cancer, coronary artery disease, and many others. Nanoantibiotics will utilize this effect to enhance infection treatment via the application of both nanoparticles with antimicrobial therapies and nanosized biological molecules for improved antibiotic drug delivery.

There is a rise in FDA approvals. A surge in innovative drugs through extensive research and developments in various diseases has created ample opportunity for this market. For instance, on 17th June 2020, Nanobiotix Company received feedback on developing effective designed platinum-based chemotherapy from the US FDA. The Company had started to advance Phase III clinical trials to treat neck and head cancer based on chemistry, manufacturing, and controls (CMC) development through necessary study design to support the future New Drug Application (NDA).

Concerns associated with nanotechnology in drug delivery is expected to hamper the market growth.

Increasing environmental concerns as nanotechnology procedure are not environment friendly that can lead to critical environmental hazards. Usage of chemicals for extraction of nanoparticles will add up in polluting environment. Health related concern is also a factor that can restraint the growth of market.

Industry Analysis

The global nanotechnology in drug delivery market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis.

Segment Analysis

Applications segment is expected to hold the largest market share in global nanotechnology in drug delivery market

The global nanotechnology in the drug delivery market is segmented based on technology, applications, and region.

In terms of technology type, the global nanotechnology in the drug delivery market is bifurcated into micelles, nanoparticles, liposomes, nanocrystals, etc. The nanoparticles segment has the highest market share due to the increasing launching of advanced technology-based nanoparticles for effective treatment and avoiding the side effects due to harmful drugs. For instance, on 5th Nov 2019, MIT engineers developed the nanoparticle coated with "right-handed" molecules to enhance drug delivery.

Depending on technology type, micelles, nanoparticles, liposomes, nanocrystals segments are also growing faster due to increasing the demand for effective treatment drugs with the rising new nano-based medicine. For instance, on 14th May 2020, NanOlogy Company had been launched a new drug delivery injection Nanopac for targeting the treatment of Pancreatic Cancer and Mucinous Cystic Neoplasms.

Depending on the applications, global nanotechnology in the drug delivery market is divided into anti-infective, neurology, anti-inflammatory/immunology, oncology, cardiovascular/physiology, and others. Among these, the anti-inflammatory/immunology segment had the highest share in 2019. This is primarily due to rising investment in developing new drugs for the immune system for various diseases. For instance, Ventus launched with $60 million from Versant Ventures and GV. Working out of dual headquarters in Waltham and Montreal, the biotech plans to create drugs that target the immune system's first defense line, known as the innate immune system. For instance, on 6th May 2020, Ventus Therapeutics Company received USD 60 Million in funding to develop medicines that have been targeted the innate immune system.

Similarly, anti-infective, neurology, oncology, cardiovascular/physiology segments are also growing faster due to the increase in the prevalence of chronic ailments like cancer, cardiovascular, neurological diseases, etc., the globe. According to the World Health Organization, an estimated 31% of all global deaths, around 17.9 million people, die each year due to cardiovascular diseases. This propels the advanced treatment methods for treating the diseases through the nanotechnology drug delivery systems.

Geographical Analysis

North America region holds the largest market share in the global nanotechnology in drug delivery market

By region, the global Nanotechnology in the Drug Delivery market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America is the dominant region for global nanotechnology in the drug delivery market. It is expected to grow at the highest CAGR during the forecasted period due to leading healthcare players with advanced technology followed by the European region. Furthermore, the rising prevalence of chronic diseases like cancer, cardiovascular, etc., in this region due to unhealthy lifestyles and diet has propelled nanotechnology's demand in the drug delivery market. According to a recent study by American Cancer Society researchers, in the United, 750000 cases were diagnosed, at least 42% of cancers cases in 2020. This propels the demand for the electronics avionics market during the forecast period.

The Asia Pacific is also growing faster for nanotechnology in the drug delivery market, owing to the prevalence of chronic diseases like cancer, cardiovascular, etc. According to the Cancer Organization in 2020, the Asia Pacific region has accounted for around 5.9 million cases were diagnosed and is projected to reach around 7.8 million new cancer cases by 2050. This will propel the demand for advanced treatment for drug delivery through nanotechnology.

Competitive Landscape

The global nanotechnology in the drug delivery market is highly competitive with several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Ceramisphere Health Pvt Limited, Cristal Therapeutics, CYTIMMUNE SCIENCES, Inc., Nanobiotix, NanoCarrier Co. Ltd., NanOlogy LLC, EnColl Corporation, EyePoint Pharmaceuticals, AbbVie Inc., Aquanova AG, BlueWillow Biologics, Camurus AB, Celgene, Inc., Lena Nanoceutics Ltd. are the leading market players with significant market share.

There is rising FDA approval for adopting advanced technology like nanotechnology to treat various chronic diseases like cancer, cardiovascular diseases, etc. has created a huge opportunity for this market. For instance, on 9th June 2020, NanOlogy Company had started clinical trials using nanotechnology-based drug delivery devices like intratumoral (IT) injections of NanoPac to treat lung cancer with FDA permission. Companies are entering into collaborations, acquisitions, mergers, and licensing for increasing their market penetration.

Key players focus on various strategic initiatives such as merger & acquisition, geographical expansion, new product launches, and increasing R&D expenditure to stay competitive. For instance, in May 2021, Nanobiotix and Lianbio announced their partnership to develop first in class radio-enhancer NBTXR3 over therapeutic combination in Asian markets.

Key Companies to Watch

AbbVie Inc:

Overview: AbbVie is America-based biopharmaceutical company that is publicly traded. It was founded in 2013 and is headquartered in Illinois, United States. Due to the spin-off of Abbott Laboratories it was originated. It is research based pharmaceutical manufacturer.

Product Portfolio:

Leupron Depot: It is injectable gonadotropin releasing hormone medication used for management of endometriosis and pain relief.

Key Developments: In March 2022, Abbvie announced its acquisition of Syndesi Therapeutics for $1 billion.

The global nanotechnology in drug delivery market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Rising approvals of nanotechnology drug delivery system
      • 4.1.1.2. Increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Increasing environmental and health risk
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
    • 6.1.2. Market Attractiveness Index, By Technology Segment
  • 6.2. Micelles for Nanotechnology in Drug Delivery the industry
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Nanoparticles
  • 6.4. Liposomes
  • 6.5. Nanocrystals
  • 6.6. Others

7. By Applications

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications Segment
    • 7.1.2. Market Attractiveness Index, By Applications Segment
  • 7.2. Anti-infective
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Neurology
  • 7.4. Anti-inflammatory/Immunology
  • 7.5. Oncology
  • 7.6. Cardiovascular/Physiology
  • 7.7. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications

9. Competitive Landscape

  • 9.1. Key Developments and Strategies
  • 9.2. Company Share Analysis
  • 9.3. Technologys Benchmarking
  • 9.4. List of Key Companies to Watch

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Technology Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Cristal Therapeutics
  • 10.3. CYTIMMUNE SCIENCES, Inc.
  • 10.4. Nanobiotix
  • 10.5. NanoCarrier Co. Ltd.
  • 10.6. NanOlogy LLC
  • 10.7. EnColl Corporation
  • 10.8. EyePoint Pharmaceuticals
  • 10.9. Ceramisphere Health Pvt Limited
  • 10.10. Aquanova AG
  • 10.11. BlueWillow Biologics
  • 10.12. Camurus AB
  • 10.13. Celgene, Inc.
  • 10.14. Lena Nanoceutics Ltd.

LIST NOT EXHAUSTIVE

11. Global Nanotechnology in Drug Delivery Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and Applications
  • 11.3. Contact Us